‘The border between the secular and sacred:’ Anthropologist receives Templeton grant for research on psychedelics, mental health, and spiritual yearning
Thanks to a major research grant, University of Notre Dame anthropologist Aidan Seale-Feldman will spend the next three years exploring how exposure to experimental mental health treatments impacts spirituality among secular Americans.
The assistant professor in the Department of Anthropology has been awarded a $370,000 grant from the John Templeton Foundation in which she will lead 10 other interdisciplinary researchers to work on the project “Ethical Substance: Psychedelic Medicine in Times of Social and Spiritual Yearning.”
The purpose of the grant is to explore the dynamic of psychedelic-assisted treatment for mental health and how it impacts spirituality in the secular world.
“In the midst of the reports on America’s growing mental health crisis, I was really drawn to the excitement around psychedelics as highly-effective treatments for things like anxiety, PTSD, addiction, and treatment-resistant depression,” Seale-Feldman said. “Maybe you could call it hype, but there's a lot of hope. It feels very hopeful, and that, to me, is exciting — that there is an emergent field of mental health care that might be revolutionary.”
Examining the impact of mystical experiences
Seale-Feldman, a medical anthropologist whose research specializes in crisis, care, and psychic life, will examine how the efficacy of psychedelic-assisted treatment of mental health issues — specifically through the use of hallucinogens such as psilocybin and ayahuasca — correlates with the presence of mystical experience and how these powerful experiences could transform relationships to spirituality among the non-religious.
“Psychedelics, in general, have always been on the border between the secular and the sacred,” she said. “In non-clinical settings, these substances are also referred to as ‘entheogens,’ and ‘sacred medicines,’ and there is a long history of Indigenous use in both religious and healing practices throughout the Americas. So there's this sense of tension (between the differing interpretations), and I'm really interested in the fact that these substances live on that border.”
Mystical experiences have been written about for hundreds of years by both religious and secularist groups and have been described as a life-changing moment that unifies the divine and dissolves the boundaries of ego. Seale-Feldman said researchers have found this experience to be key in psychedelic treatment efficacy, and she is curious about the after-effects.
“The focus of the project is really on this question of the incorporation of mystical experiences into the lives of secular Americans and their therapeutic practices,’” Seale-Feldman said. “And we’re exploring what the impact of this might be in times of social and spiritual crisis.”
Advancing research with interdisciplinary work
Seale-Feldman is now leading a team of scholars — who specialize in anthropology, psychiatry, clinical psychology, philosophy, theology, and religious studies — to conduct and analyze research at four field sites over three years. The sites include a clinical trial for psilocybin-assisted palliative care, psychedelic churches, a psychedelic-therapy training program, and psychedelic science conferences.
“The focus of the project is really on this question of the incorporation of mystical experiences into the lives of secular Americans and their therapeutic practices. And we’re exploring what the impact of this might be in times of social and spiritual crisis.”
By the end, she said, their work will result in a number of published articles, an ethnographic book manuscript, podcast episodes, and a public workshop at the renowned retreat center Esalen Institute in California.
Both mental health and psychedelics have been marred by cultural taboos and stigma, but Seale-Feldman said this grant signals a shift in public perception of the topics.
“Given the state of mental health in the U.S. right now, I think we need to be as open-minded as possible in exploring a wide range of pathways towards healing,” she said. “And to also ask how the resurgence of interest in psychedelic medicine might impact people's lives beyond the area of mental health and into domains related to spirituality and meaning.”
Seale-Feldman is excited to approach this research through an anthropological lens and work with experts across interdisciplinary disciplines. The hope, she said, is that their findings will contribute to the current research dialogue, which has been primarily dictated by a psychiatric approach.
“I think it’s a really exciting new direction,” Seale-Feldman said. “There’s a lot of hype and narrative surrounding the so-called ‘psychedelic renaissance,’ so I’m hoping this research can be a kind of empirical study of that — to explore the impacts these experiences have on people and how psychedelic medicine could reconfigure our whole way of thinking about mental health care.”
Originally published by al.nd.edu on March 27, 2024.
atLatest Research
- Notre Dame theologian to receive 2024 Ratzinger Prize from VaticanCyril O’Regan, the Catherine F. Huisking Professor of Theology at the University of Notre Dame, has been selected to receive the 2024 Ratzinger Prize in Theology, widely regarded as the most prestigious award in the field. Pietro Parolin, the Vatican’s secretary of state, will present the award to O’Regan and to sculptor Etsurō Sotoo during a ceremony at the Apostolic Palace in Vatican City on Nov. 22. Both winners will also have an audience with Pope Francis earlier that day.
- Four First-Year Students Named 2024-25 Murphy Fellows at Notre Dame Law SchoolNotre Dame Law School has announced the selection of four first-year law students—David Jordan, Maddie Kosobucki, Catherine Kolesar, and Jack McEnery—as the 2024-25 Murphy Fellows. Established in 2022, the Murphy Fellowship supports students who are interested in exploring the intersection of law…
- ND Expert Sean Kassen: Statement on first FDA-approved treatment for Niemann-Pick Type C diseaseToday, the FDA announced the first approved treatment for Niemann-Pick Type C (NPC) disease: an oral medication named Miplyffa (arimoclomol). Sean Kassen, director of the Ara Parseghian Medical Research Fund at the University of Notre Dame, said this represents the beginning of a new and hopeful era for NPC families.
- What Would You Fight For: Notre Dame psychologists combating America's mental health crisisAustin Wyman ’23 was young when the mental health crisis hit home. A struggling family member reached out to a provider for help, but with no immediately available appointments, the relative soon had a mental health episode. The situation ended in the death of two of Wyman’s family members, and left…
- Notre Dame to host conference on St. Thomas Aquinas, commemorating 800th anniversary of his birthTo commemorate the 800th anniversary of his birth, the University of Notre Dame will host a conference Sunday through Wednesday (Sept. 22-25) celebrating Aquinas’ enduring importance to contemporary cultural, philosophical and theological discussions. “Aquinas at 800: ‘Ad multos annos’” will be the largest conference of its kind, with more than 500 in-person attendees and more than 150 speakers.
- From Italy to South Sudan and back again: MGA graduate aims for peace through shuttle diplomacySince she first began working for the Rome-based Community of Sant’Egidio as an intern in 2021, Elizabeth Boyle MGA ’23 has boarded more flights to Juba, South Sudan than she has to her Long Island hometown in the United States. As an international relations officer for …